Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Galpha Subunit

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Aug 4

PMID 19648112

Citations 39

Authors

Mohammed Akli Ayoub

Marjorie Damian

Christian Gespach

Eric Ferrandis

Olivier Lavergne

Olivier de Wever

Jean-Louis Baneres

Jean-Philippe Pin

Gregoire Pierre Prevost

Affiliations

Soon will be listed here.

Abstract

The simultaneous activation of many distinct G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play a major role in various pathological conditions. Pan-inhibition of GPCR signaling by small molecules thus represents a novel strategy to treat various diseases. To better understand such therapeutic approach, we have characterized the biomolecular target of BIM-46187, a small molecule pan-inhibitor of GPCR signaling. Combining bioluminescence and fluorescence resonance energy transfer techniques in living cells as well as in reconstituted receptor-G protein complexes, we observed that, by direct binding to the Galpha subunit, BIM-46187 prevents the conformational changes of the receptor-G protein complex associated with GPCR activation. Such a binding prevents the proper interaction of receptors with the G protein heterotrimer and inhibits the agonist-promoted GDP/GTP exchange. These observations bring further evidence that inhibiting G protein activation through direct binding to the Galpha subunit is feasible and should constitute a new strategy for therapeutic intervention.

Citing Articles

Essential strategies for the detection of constitutive and ligand-dependent Gi-directed activity of 7TM receptors using bioluminescence resonance energy transfer.

Endzhievskaya S, Chahal K, Resnick J, Khare E, Roy S, Handel T bioRxiv. 2024; .

PMID: 39713355 PMC: 11661105. DOI: 10.1101/2024.12.04.626681.

Red blood cell signaling is functionally conserved in invasion.

Yong J, Gao X, Prakash P, Ang J, Lai S, Chen M iScience. 2024; 27(10):111052.

PMID: 39635131 PMC: 11615254. DOI: 10.1016/j.isci.2024.111052.

Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated G in Human Cancer.

Dwyer M, Aumiller J, Wedegaertner P Mol Pharmacol. 2024; 106(5):198-215.

PMID: 39187387 PMC: 11493338. DOI: 10.1124/molpharm.124.000743.

LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration.

Hong J, Lee J, Seen D, Jeong J, Huh W Cell Commun Signal. 2023; 21(1):257.

PMID: 37749552 PMC: 10518940. DOI: 10.1186/s12964-023-01261-7.

Soluble amyloid-β precursor peptide does not regulate GABA receptor activity.

Rem P, Sereikaite V, Fernandez-Fernandez D, Reinartz S, Ulrich D, Fritzius T Elife. 2023; 12.

PMID: 36688536 PMC: 9917443. DOI: 10.7554/eLife.82082.

References

Rodrigues S, Van Aken E, Van Bocxlaer S, Attoub S, Nguyen Q, Bruyneel E . Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J. 2003; 17(1):7-16. DOI: 10.1096/fj.02-0201com. View

Neubig R, Siderovski D . Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov. 2002; 1(3):187-97. DOI: 10.1038/nrd747. View

Nobles M, Benians A, Tinker A . Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc Natl Acad Sci U S A. 2005; 102(51):18706-11. PMC: 1317907. DOI: 10.1073/pnas.0504778102. View

Favre-Guilmard C, Zeroual-Hider H, Soulard C, Touvay C, Chabrier P, Prevost G . The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine. Eur J Pharmacol. 2008; 594(1-3):70-6. DOI: 10.1016/j.ejphar.2008.07.016. View

Nguyen Q, Faivre S, Bruyneel E, Rivat C, Seto M, Endo T . RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion. FASEB J. 2002; 16(6):565-76. DOI: 10.1096/fj.01-0525com. View

Baneres J, Parello J . Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol. 2003; 329(4):815-29. DOI: 10.1016/s0022-2836(03)00439-x. View

Taniguchi M, Nagai K, Arao N, Kawasaki T, Saito T, Moritani Y . YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666. J Antibiot (Tokyo). 2003; 56(4):358-63. DOI: 10.7164/antibiotics.56.358. View

Breitweg-Lehmann E, Czupalla C, Storm R, Kudlacek O, Schunack W, Freissmuth M . Activation and inhibition of G proteins by lipoamines. Mol Pharmacol. 2002; 61(3):628-36. DOI: 10.1124/mol.61.3.628. View

Ayoub M, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M . Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem. 2002; 277(24):21522-8. DOI: 10.1074/jbc.M200729200. View

10.

Oldham W, Van Eps N, Preininger A, Hubbell W, Hamm H . Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. Nat Struct Mol Biol. 2006; 13(9):772-7. DOI: 10.1038/nsmb1129. View

11.

Gales C, Van Durm J, Schaak S, Pontier S, Percherancier Y, Audet M . Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol. 2006; 13(9):778-86. DOI: 10.1038/nsmb1134. View

12.

Holler C, Freissmuth M, Nanoff C . G proteins as drug targets. Cell Mol Life Sci. 1999; 55(2):257-70. PMC: 11147085. DOI: 10.1007/s000180050288. View

13.

Ahmad S, Dray A . Novel G protein-coupled receptors as pain targets. Curr Opin Investig Drugs. 2004; 5(1):67-70. View

14.

Bonacci T, Mathews J, Yuan C, Lehmann D, Malik S, Wu D . Differential targeting of Gbetagamma-subunit signaling with small molecules. Science. 2006; 312(5772):443-6. DOI: 10.1126/science.1120378. View

15.

Higashijima T, Uzu S, Nakajima T, Ross E . Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem. 1988; 263(14):6491-4. View

16.

Hickerson M, Cunningham C . Dramatic mitochondrial gene rearrangements in the hermit crab Pagurus longicarpus (Crustacea, anomura). Mol Biol Evol. 2000; 17(4):639-44. DOI: 10.1093/oxfordjournals.molbev.a026342. View

17.

Gales C, Rebois R, Hogue M, Trieu P, Breit A, Hebert T . Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods. 2005; 2(3):177-84. DOI: 10.1038/nmeth743. View

18.

Dorsam R, Gutkind J . G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007; 7(2):79-94. DOI: 10.1038/nrc2069. View

19.

Cotecchia S, Fanelli F, Costa T . Constitutively active G protein-coupled receptor mutants: implications on receptor function and drug action. Assay Drug Dev Technol. 2004; 1(2):311-6. DOI: 10.1089/15406580360545125. View

20.

Nanoff C, Kudlacek O, Freissmuth M . Development of Gs-selective inhibitory compounds. Methods Enzymol. 2002; 344:469-80. DOI: 10.1016/s0076-6879(02)44734-9. View